TY - JOUR
T1 - Minocycline in rheumatoid arthritis
AU - Langevitz, P.
AU - Livneh, A.
AU - Bank, I.
AU - Pras, M.
PY - 1996/5
Y1 - 1996/5
N2 - Rheumatoid arthritis (RA) is a chronic, potentially incapacitating disease of unknown etiology that affects the many systems of the human body, most notably the synovial lining of the joints. Clinicians have suggested that RA may have an infectious etiology, with possible agents including viruses and bacteria such as Mycoplasma. They believe that tetracycline antibiotics, especially minocycline, are the appropriate treatment for RA. Several clinical studies on minocycline therapy have shown that it is an effective and adequately tolerated drug in patients with RA, including those who did not respond to previous therapies.
AB - Rheumatoid arthritis (RA) is a chronic, potentially incapacitating disease of unknown etiology that affects the many systems of the human body, most notably the synovial lining of the joints. Clinicians have suggested that RA may have an infectious etiology, with possible agents including viruses and bacteria such as Mycoplasma. They believe that tetracycline antibiotics, especially minocycline, are the appropriate treatment for RA. Several clinical studies on minocycline therapy have shown that it is an effective and adequately tolerated drug in patients with RA, including those who did not respond to previous therapies.
KW - Minocycline
KW - Rheumatoid arthritis
UR - http://www.scopus.com/inward/record.url?scp=0030152736&partnerID=8YFLogxK
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.shortsurvey???
AN - SCOPUS:0030152736
VL - 32
SP - 327
EP - 330
JO - Israel Medical Association Journal
JF - Israel Medical Association Journal
SN - 1565-1088
IS - 5
ER -
